Osteoporosis and bone marrow mastocytosis: Dissociation of skeletal responses and mast cell activity during long-term bisphosphonate therapy

Journal of Bone and Mineral Research

Volumn 17, Issue 4, 2002, Pages 567-569

  Brumsen, Caroline ^a   Hamdy, Neveen A T ^a   Papapoulos, Socrates E ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; COLECALCIFEROL; PAMIDRONIC ACID;

ADULT; ARTICLE; BONE MARROW DISEASE; BONE METABOLISM; CASE REPORT; CELL ACTIVITY; CLINICAL FEATURE; DISEASE COURSE; HUMAN; LONG TERM CARE; MALE; MAST CELL; MASTOCYTOSIS; OSTEOPENIA; OSTEOPOROSIS;

EID: 0036128440     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2002.17.4.567     Document Type: Article

References (10)

1. Osteoporosis as the sole presentation of bone marrow mastocytosis
2. Bone mastocytosis, a report of nine cases with a bone histomorphometric study
3. Skeletal mastocytosis
4. Osteoporosis associated with mastocytosis confined to bone: Report of two cases
5. The osteoporosis of heparinotherapy and systemic mastocytosis
6. Increased production of prostaglandin D2 in patients with systemic mastocytosis
7. Mast cells as a source of multifunctional cytokines
8. Inhibition of mediator release in systemic mastocytosis is associated with reversal of bone changes
9. Osteopenia in systemic mastocytosis: Natural history and responses to treatment with inhibitors of bone resorption
10. The effect of pamidronate on lumbar spine bone density and pain in osteoporosis secondary to systemic mastocytosis